GlaxoSmithKline Pharmaceuticals

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue848.891,0141,0731,031982.20
Expenses569.91662.15691.43658.15659.75
EBITDA294.92369.30403.46386.88339.26
Operating Profit279.40354.51401.12373.71323.42
Profit Before Tax278.98354.00399.93373.10322.45
Net Profit205.01257.49295.62277.86237.18
Financial Ratios
Operating Profit Margin36.63%37.96%40.47%38.87%36.15%
Net Profit Margin25.46%26.08%27.11%27.92%25.27%
Earning Per Share (Diluted)12.1015.0217.4516.4014.00
Dividends Per Share0.000.000.000.000.00